Cipla surges on reporting decent Q2 numbers

16 Nov 2011 Evaluate

Cipla is currently trading at Rs 309.05, up by 2.15 points or 0.70% from its previous closing of Rs 306.90 on the BSE.

The scrip opened at Rs 307.50 and has touched a high and low of Rs 310.80 and Rs 306.00 respectively. So far 167166 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 380.80 on 04-Jan-2011 and a 52 week low of Rs 273.60 on 06-Sep-2011.

Last one week high and low of the scrip stood at Rs 310.80 and Rs 284.00 respectively. The current market cap of the company is Rs 24641.66 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 33.43% and 29.62% respectively. 

India’s second largest drug maker by domestic sales, Cipla has reported a jump of 17.44% in its standalone net profit at Rs 308.97 crore for the second quarter ended September 30, 2011 on increased sales and cost savings. The company had posted a net profit of Rs 263.08 crore in the July-September quarter of the previous fiscal.

Total income of the company also rose by 9.16% to Rs 1802.33 crore during the reporting quarter from Rs 1651.03 crore in the year-ago period.

Exports to Africa were up 41% and the firm benefited from operational efficiencies in material consumption and product mix. Cipla’s sales in the domestic market grew on expected lines by 12%. Sales in Middle East were affected by changed market circumstances.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 15:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×